Ferozi-Ci .


Ferozi-Ci .


Stock Status:

In Stock

  • *Upload Prescription

    • (max file size 80 MB)


Indication of Ferozi-CI

It is shown for the treatment and prophylaxis of Press, Folic Corrosive and Zinc insufficiency particularly amid pregnancy and lactation.


Pharmaceutical Name

Drug International Ltd.



This timed-release capsule is the combined planning of Carbonyl Press, Folic Corrosive and Zinc Sulfate Monohydrate. It contains Carbonyl Press with not less than 98% Press substance. Carbinyl Press, having tall bioavailability and moo poisonous quality is more secure and more viable choice for press supplementation.


Dosage & Administration of Ferozi-CI

Adult: One Capsule day by day some time recently nourishment or as coordinated by the doctor.


Interaction of Ferozi-CI

Carbonyl Press diminishes the assimilation of tetracycline anti-microbials, quinolone anti-microbials, levodopa, levothyroxine, methyldopa and penecillamine. Folic Corrosive interatomic with antiepileptics, so plasma concentrations of phenobarbital, phenytoin and primidone are conceivably decreased.



It is contraindicated in patients with known touchiness to any of its component or those with Press over-burden.


Side effects of Ferozi-CI

Gastrointestinal aggravations such as sickness, anorexia, heaving, distress, clogging and loose bowels may happen. Patients may complain of dim stool. Carbonyl Press pellets consolidated into the capsules to diminish the plausibility of gastrointestinal disturbances. Once in a while there may be unfavorably susceptible responses.


Pregnancy & Lactation

Utilize of any sedate amid to begin with trimester of pregnancy ought to be dodged in case conceivable. Hence organization of Press amid the primary trimester requires positive prove of Press lack. Prophylaxis of Press lack where lacking slim down calls for supplementary Zinc and Folic corrosive is legitimized amid the leftover portion of pregnancy.


Precautions & Warnings

Uncommon care ought to be taken in patients with Press over-burden states, such as haemochromatosis, haemolytic weakness or ruddy blood cell aplasia. Disappointment to reaction to the treatment requires advance examinations to prohibit other causes of weakness. In patients with renal disappointment there may be the hazard of Zinc aggregation.


Therapeutic Class

Iron, Vitamin & Mineral Combined preparation


Storage Conditions

Store below 30°C. and keep away from light and moisture. Keep all medicines out of the reach of children.


Generic Name of Ferozi-CI

Carbonyl Iron + Folic Acid + Zinc Sulfate